Watch: CNBC’s Becky Quick Leads Rare Disease CEO Dialogue

Featured Session | 2026 NORD^® Breakthrough Summit^®

What will it take to accelerate rare disease innovation and bring more treatments to more patients over the next decade?

At the 2026 NORD Breakthrough Summit, CNBC’s Becky Quick moderated a compelling discussion with leading pharmaceutical executives and NORD’s CEO on the future of rare disease research, drug development, and patient access.

Featured Speakers

Hear from leaders shaping the future of rare disease innovation and patient care.

Moderator

Becky Quick
Co-anchor, CNBC’s Squawk Box and Host, CNBC Cures

Panelists

Renee Gala
President and Chief Executive Officer
Jazz Pharmaceuticals

Pam Gavin
President and Chief Executive Officer
National Organization for Rare Disorders (NORD)

Alexander Hardy
President and Chief Executive Officer
BioMarin

Tarek Rabah
President and Chief Executive Officer
Otsuka North America Pharmaceutical